0001686266-18-000012.txt : 20180925 0001686266-18-000012.hdr.sgml : 20180925 20180924173232 ACCESSION NUMBER: 0001686266-18-000012 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180925 DATE AS OF CHANGE: 20180924 EFFECTIVENESS DATE: 20180925 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Armis Biopharma, Inc. CENTRAL INDEX KEY: 0001604801 IRS NUMBER: 841445770 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-322045 FILM NUMBER: 181084270 BUSINESS ADDRESS: STREET 1: 2950 EAST HARMONY STREET 2: SUITE 252 CITY: FORT COLLINS STATE: CO ZIP: 80528 BUSINESS PHONE: 970-295-4373 MAIL ADDRESS: STREET 1: 2950 EAST HARMONY STREET 2: SUITE 252 CITY: FORT COLLINS STATE: CO ZIP: 80528 FORMER COMPANY: FORMER CONFORMED NAME: CHD Bioscience, Inc. DATE OF NAME CHANGE: 20140404 D 1 primary_doc.xml X0708 D LIVE 0001604801 Armis Biopharma, Inc. 2950 EAST HARMONY SUITE 252 FORT COLLINS CO COLORADO 80528 970-295-4373 COLORADO CHD Bioscience, Inc. Corporation true Dennis Templar 2950 East Harmony Suite 252 Fort Collins CO COLORADO 80528 Executive Officer Director Robert Kali 2950 East Harmony Suite 252 Fort Collins CO COLORADO 80528 Executive Officer Stephen Coder 2950 East Harmony Suite 252 Fort Collins CT CONNECTICUT 80528 Director Alan Ruud 2950 East Harmony Suite 252 Fort Collins CO COLORADO 80528 Director Ed Neas 2950 East Harmony Suite 252 Fort Collins CO COLORADO 80528 Director Alan Smith 2950 East Harmony Suite 252 Fort Collins CO COLORADO 80528 Director Ted Ziemann 2950 East Harmony Suite 252 Fort Collins CO COLORADO 80528 Executive Officer Director William Nelson 2950 East Harmony Suite 252 Fort Collins CO COLORADO 80528 Director Michael Litwack 2950 East Harmony Suite 252 Fort Collins CO COLORADO 80528 Director Other Health Care Decline to Disclose 06b false 2018-06-22 false true false 0 Arete Wealth Management, LLC 44856 None None 1101 W. Lake St First Floor Chicago IL ILLINOIS 60607 All States false 10000000 1832300 8167700 false 19 490062 0 Assumes maximum commissions earned by one or more non-exclusive agents or sub agents as more fully set forth in the offering materials. Excludes warrants to purchase 544,513 shares. 0 Some of the proceeds may be used for general working capital purposes including the payment of salaries and other fees to those listed in Item 3. false Armis Biopharma, Inc. /s/ Robert Kali Robert Kali Chief Financial Officer 2018-09-24